Satsuma Pharmaceuticals Eulerpool Ziņas

Satsuma Pharmaceuticals Eulerpool News

Satsuma Pharmaceuticals Akciju Ziņas

Satsuma Pharmaceuticals tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Satsuma Pharmaceuticals ziņas mēs apkopojam šeit.

• 17. jūlijs ·

  SeekingAlpha
  Leaven Partners Second Quarter 2023 Letter To Partners
• 9. jūnijs ·

  Benzinga
  Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
• 18. maijs ·

  Yahoo
  Satsuma Pharmaceuticals Announces FDA Acceptance of 505(b)(2) NDA for STS101, a Novel and Investigational Dihydroergotamine (DHE) Nasal Powder Product for the Acute Treatment of Migraine
• 18. maijs ·

  Seeking Alpha
  Satsuma migraine therapy accepted for FDA review
• 18. maijs ·

  Thefly.com
  Satsuma: FDA accepts NDA for STS101 for acute migraine treatment
• 15. maijs ·

  TipRanks
  JonesTrading Sticks to Its Hold Rating for Satsuma Pharmaceuticals (STSA)
• 21. aprīlis ·

  Yahoo
  Satsuma Pharmaceuticals Announces Three Abstracts Accepted at The 75th American Academy of Neurology Annual Meeting
• 21. aprīlis ·

  Thefly.com
  Satsuma Pharmaceuticals announces three abstracts accepted at AAN meeting
• 19. aprīlis ·

  Thefly.com
  Biotech Alert: Searches spiking for these stocks today
• 19. aprīlis ·

  Fintel
  HC Wainwright & Co. Downgrades Satsuma Pharmaceuticals (STSA)